Key facts
- It has raised $121.5M across 4 recorded rounds; the latest was Early Stage VC ($33.5M) in Aug 2021.
- Notable investors include MedTech Innovator, Canaan Partners, SV Health Investors, 1315 Capital, 3D Systems — 8 tracked in total.
- Onkos Surgical has filed 9 Form Ds with the SEC since 2015, most recently May 2023 ($33.5M sold to 17 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Onkos Surgical
Funding rounds
4 roundsAbout Onkos Surgical
Developer of precision orthopedics designed to reduce complexity and address the clinical challenges of musculoskeletal cancers and complex conditions. The company's products are rooted in unmatched expertise in patient imaging analysis, personalized surgical planning, and the latest advancements in three-dimensional printing, enabling healthcare professionals to reduce complexity and address the clinical challenges associated with tumor surgery.
- Sector
- Healthcare
- HQ
- Parsippany, NJ, United States
- Founded
- 2015
- Employees
- 105
- Website
- onkossurgical.com/
- Ownership
- Privately Held (backing)
Onkos Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Onkos Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Onkos Surgical in its N-PORT filings yet. We sweep new filings monthly.